Trial intelligence / Profile preview

Spinal vs. Inhalational Anesthesia in Infants

NCT02521831Phase 3Withdrawn

Start
Oct 2015
Primary completion
Dec 2017
Modality
Allosteric Modulators
01

Overview

Phase 3, randomised, double-blind trial of bupivacaine and isoflurane in inguinal hernia (2 arms). Primary endpoint: Change in proinflammatory miRNAs. Planned start Oct 2015; status: withdrawn.

02

Drugs

bupivacaineisoflurane
03

Conditions

inguinal hernia

Beyond the preview

Go deeper on NCT02521831.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02521831.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call